• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在肝细胞腺瘤的管理中,决策模型是否合理?

Can a decision-making model be justified in the management of hepatocellular adenoma?

机构信息

Department of Surgery, Erasmus Medical Centre, Rotterdam, the Netherlands.

出版信息

Liver Int. 2012 Jan;32(1):28-37. doi: 10.1111/j.1478-3231.2011.02667.x. Epub 2011 Oct 21.

DOI:10.1111/j.1478-3231.2011.02667.x
PMID:22098685
Abstract

During recent years, there was a great development in the area of hepatocellular adenomas (HCA), especially regarding the pathological subtype classification, radiological imaging and management during pregnancy. This review discusses the current knowledge about diagnosis and treatment modalities of HCA and proposes a decision-making model for HCA. A Medline search of studies relevant to epidemiology, histopathology, complications, imaging and management of HCA lesions was undertaken. References from identified articles were hand-searched for further relevant articles.

摘要

近年来,肝细胞腺瘤(HCA)领域取得了很大的发展,特别是在病理亚型分类、影像学诊断和妊娠期间的管理方面。本文综述了 HCA 的诊断和治疗方法的最新知识,并提出了 HCA 的决策模型。对与 HCA 的流行病学、组织病理学、并发症、影像学和管理相关的研究进行了 Medline 检索,并对确定的文章的参考文献进行了手工检索,以寻找进一步的相关文章。

相似文献

1
Can a decision-making model be justified in the management of hepatocellular adenoma?在肝细胞腺瘤的管理中,决策模型是否合理?
Liver Int. 2012 Jan;32(1):28-37. doi: 10.1111/j.1478-3231.2011.02667.x. Epub 2011 Oct 21.
2
Hepatocellular adenomas: current update on genetics, taxonomy, and management.肝细胞腺瘤:遗传学、分类学及管理的最新进展
J Comput Assist Tomogr. 2011 Mar-Apr;35(2):159-66. doi: 10.1097/RCT.0b013e31820bad61.
3
Pregnancy and liver adenoma management: PALM-study.妊娠合并肝腺瘤的管理:PALM 研究。
BMC Gastroenterol. 2012 Jun 29;12:82. doi: 10.1186/1471-230X-12-82.
4
Resection, transplantation and local regional therapies for liver adenomas.肝腺瘤的切除术、移植术及局部区域治疗
Expert Rev Gastroenterol Hepatol. 2014 Sep;8(7):803-10. doi: 10.1586/17474124.2014.917957. Epub 2014 Jun 24.
5
A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management.妊娠期肝脏肿块综述及诊断与管理的建议算法。
Am J Surg. 2004 Feb;187(2):181-91. doi: 10.1016/j.amjsurg.2003.11.016.
6
Diagnosis and treatment of benign focal liver lesions.良性局灶性肝病变的诊断与治疗
Scand J Gastroenterol Suppl. 2006(243):102-15. doi: 10.1080/00365520600664391.
7
[Differential diagnosis and therapy of benign liver tumors].[肝脏良性肿瘤的鉴别诊断与治疗]
Ther Umsch. 1998 Feb;55(2):120-6.
8
Hepatic adenomas: imaging and pathologic findings.肝腺瘤:影像学与病理表现
Radiographics. 2001 Jul-Aug;21(4):877-92; discussion 892-4. doi: 10.1148/radiographics.21.4.g01jl04877.
9
[Diagnostics and treatment of hepatocellular adenomas].[肝细胞腺瘤的诊断与治疗]
Ned Tijdschr Geneeskd. 2016;160:D556.
10
Management of hepatocellular adenoma during pregnancy.妊娠合并肝细胞腺瘤的处理。
J Hepatol. 2011 Mar;54(3):553-8. doi: 10.1016/j.jhep.2010.07.022. Epub 2010 Sep 22.

引用本文的文献

1
Safety of hormonal contraception among women with liver disease: an updated systematic review.肝病女性使用激素避孕的安全性:一项更新的系统评价。
Contraception. 2025 Jul 7:111012. doi: 10.1016/j.contraception.2025.111012.
2
Hepatocellular adenomas with severe intra-abdominal bleeding, related to an underlying coagulation disorder: a case report.伴有严重腹腔内出血的肝细胞腺瘤,与潜在的凝血障碍相关:一例报告。
J Med Case Rep. 2024 Aug 13;18(1):367. doi: 10.1186/s13256-024-04709-7.
3
Living-Donor Liver Transplantation for a Large Hepatocellular Carcinoma in a Genetically Identical Twin Sister.
活体供肝肝移植治疗同卵双胞胎姐妹的巨大肝细胞癌
Z Gastroenterol. 2024 Jan;62(1):56-61. doi: 10.1055/a-2214-1712. Epub 2024 Jan 9.
4
KETOgenic diet therapy in patients with HEPatocellular adenoma: study protocol of a matched interventional cohort study.生酮饮食疗法治疗肝细胞腺瘤患者:一项配对干预队列研究的研究方案。
BMJ Open. 2022 Feb 15;12(2):e053559. doi: 10.1136/bmjopen-2021-053559.
5
Molecular classification of hepatocellular adenomas: impact on clinical practice.肝细胞腺瘤的分子分类:对临床实践的影响。
Hepat Oncol. 2018 Apr 9;5(1):HEP04. doi: 10.2217/hep-2017-0023. eCollection 2018 Jan.
6
Malignant transformation of hepatocellular adenoma.肝细胞腺瘤的恶性转化
Hepat Oncol. 2014 Oct;1(4):421-431. doi: 10.2217/hep.14.14. Epub 2014 Dec 11.
7
Current Approaches in the Management of Hepatic Adenomas.当前肝腺瘤的治疗方法。
J Gastrointest Surg. 2019 Jan;23(1):199-209. doi: 10.1007/s11605-018-3917-4. Epub 2018 Aug 14.
8
Growth of Focal Nodular Hyperplasia is Not a Reason for Surgical Intervention, but Patients Should be Referred to a Tertiary Referral Centre.局灶性结节性增生的生长并非手术干预的理由,但患者应转诊至三级转诊中心。
World J Surg. 2018 May;42(5):1506-1513. doi: 10.1007/s00268-017-4335-6.
9
Screening the key genes of hepatocellular adenoma via microarray analysis of DNA expression and methylation profiles.通过DNA表达和甲基化谱的微阵列分析筛选肝细胞腺瘤的关键基因。
Oncol Lett. 2017 Oct;14(4):3975-3980. doi: 10.3892/ol.2017.6673. Epub 2017 Jul 26.
10
Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma.健康肝脏的良性肝细胞结节:局灶性结节性增生和肝细胞腺瘤。
Clin Mol Hepatol. 2016 Jun;22(2):199-211. doi: 10.3350/cmh.2016.0101. Epub 2016 May 18.